Lipe & Dalton’s Cigna CI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.22M | Sell |
4,437
-273
| -6% | -$77.1K | 0.57% | 44 |
|
|
2026
Q1 | $1.26M | Buy |
4,710
+2
| +0% | +$553 | 0.66% | 40 |
|
|
2025
Q4 | $1.3M | Sell |
4,708
-308
| -6% | -$86.3K | 0.64% | 44 |
|
|
2025
Q3 | $1.45M | Sell |
5,016
-183
| -4% | -$54.1K | 0.72% | 43 |
|
|
2025
Q2 | $1.72M | Sell |
5,199
-14
| -0.3% | -$4.51K | 0.93% | 39 |
|
|
2025
Q1 | $1.72M | Sell |
5,213
-619
| -11% | -$186K | 0.96% | 37 |
|
|
2024
Q4 | $1.61M | Sell |
5,832
-199
| -3% | -$63.4K | 0.85% | 36 |
|
|
2024
Q3 | $2.09M | Buy |
6,031
+1
| +0% | +$344 | 1.06% | 35 |
|
|
2024
Q2 | $1.99M | Sell |
6,030
-31
| -0.5% | -$10.7K | 1.07% | 36 |
|
|
2024
Q1 | $2.2M | Buy |
6,061
+1
| +0% | +$329 | 1.13% | 33 |
|
|
2023
Q4 | $1.81M | Sell |
6,060
-49
| -0.8% | -$14.3K | 0.98% | 35 |
|
|
2023
Q3 | $1.75M | Buy |
6,109
+1
| +0% | +$285 | 1.05% | 33 |
|
|
2023
Q2 | $1.71M | Hold |
6,108
| – | – | 0.98% | 36 |
|
|
2023
Q1 | $1.56M | Sell |
6,108
-175
| -3% | -$51K | 0.89% | 37 |
|
|
2022
Q4 | $2.08M | Buy |
6,283
+21
| +0.3% | +$6.64K | 1.2% | 30 |
|
|
2022
Q3 | $1.74M | Hold |
6,262
| – | – | 1.09% | 32 |
|
|
2022
Q2 | $1.65M | Hold |
6,262
| – | – | 0.97% | 37 |
|
|
2022
Q1 | $1.5M | Sell |
6,262
-60
| -0.9% | -$14K | 0.73% | 40 |
|
|
2021
Q4 | $1.45M | Sell |
6,322
-89
| -1% | -$18.9K | 0.69% | 41 |
|
|
2021
Q3 | $1.28M | Sell |
6,411
-175
| -3% | -$38.1K | 0.66% | 43 |
|
|
2021
Q2 | $1.56M | Buy |
6,586
+1
| +0% | +$250 | 0.81% | 39 |
|
|
2021
Q1 | $1.59M | Sell |
6,585
-230
| -3% | -$51.3K | 0.88% | 38 |
|
|
2020
Q4 | $1.42M | Sell |
6,815
-50
| -0.7% | -$9.81K | 0.87% | 38 |
|
|
2020
Q3 | $1.16M | Sell |
6,865
-85
| -1% | -$15K | 0.81% | 41 |
|
|
2020
Q2 | $1.3M | Sell |
6,950
-200
| -3% | -$37.9K | 0.95% | 37 |
|
|
2020
Q1 | $1.27M | Sell |
7,150
-697
| -9% | -$135K | 1.07% | 33 |
|
|
2019
Q4 | $1.6M | Sell |
7,847
-500
| -6% | -$91.7K | 1.06% | 34 |
|
|
2019
Q3 | $1.27M | Sell |
8,347
-2,777
| -25% | -$452K | 0.92% | 38 |
|
|
2019
Q2 | $1.75M | Sell |
11,124
-178
| -2% | -$27.9K | 1.25% | 31 |
|
|
2019
Q1 | $1.82M | Sell |
11,302
-673
| -6% | -$123K | 1.34% | 29 |
|
|
2018
Q4 | $2.27M | Buy |
11,975
+2,825
| +31% | +$589K | 1.85% | 23 |
|
|
2018
Q3 | $1.91M | Sell |
9,150
-50
| -0.5% | -$9.27K | 1.3% | 31 |
|
|
2018
Q2 | $1.56M | Sell |
9,200
-2,612
| -22% | -$452K | 1.15% | 35 |
|
|
2018
Q1 | $1.98M | Sell |
11,812
-250
| -2% | -$48.6K | 1.42% | 28 |
|
|
2017
Q4 | $2.45M | Sell |
12,062
-920
| -7% | -$183K | 1.69% | 26 |
|
|
2017
Q3 | $2.43M | Sell |
12,982
-1,978
| -13% | -$352K | 1.71% | 30 |
|
|
2017
Q2 | $2.5M | Buy |
14,960
+125
| +0.8% | +$20.1K | 1.62% | 32 |
|
|
2017
Q1 | $2.17M | Sell |
14,835
-1,035
| -7% | -$153K | 1.57% | 29 |
|
|
2016
Q4 | $2.12M | Sell |
15,870
-542
| -3% | -$70.9K | 1.51% | 30 |
|
|
2016
Q3 | $2.14M | Buy |
16,412
+662
| +4% | +$86.4K | 1.43% | 32 |
|
|
2016
Q2 | $2.02M | Buy |
15,750
+955
| +6% | +$126K | 1.39% | 31 |
|
|
2016
Q1 | $2.03M | Buy |
14,795
+2,540
| +21% | +$349K | 1.6% | 27 |
|
|
2015
Q4 | $1.79M | Buy |
+12,255
| New | +$1.68M | 1.45% | 28 |
|
|
2015
Q2 | – | Sell |
-32,505
| Closed | -$4.21M | – | 67 |
|
|
2015
Q1 | $4.21M | Buy |
+32,505
| New | +$3.78M | 2.9% | 17 |
|
Other funds holding CI
Lipe & Dalton's CI Position: Q2 2026 in Review
Lipe & Dalton reduced its Cigna (CI) stake by 5.8% in Q2 2026, selling an estimated $77.1K and leaving 4,437 shares worth $1.22M. The position accounts for 0.57% of the portfolio, ranked #44.
Lipe & Dalton first reported a position in CI in Q1 2015 and has held it in 44 quarters since. The position peaked at $4.21M in Q1 2015. 1,692 funds tracked by Wall St. Rank hold CI as of Q2 2026.
- Lipe & Dalton held 4,437 shares of Cigna worth $1.22M as of Q2 2026.
- Lipe & Dalton sold 273 Cigna shares in Q2 2026, an estimated $77.1K.
- Cigna made up 0.57% of Lipe & Dalton's portfolio in Q2 2026, its #44 holding.
- Lipe & Dalton first reported a position in Cigna in Q1 2015 and has held it in 44 quarters since.
- Lipe & Dalton's Cigna position peaked at $4.21M in Q1 2015.
- 1,692 funds tracked by Wall St. Rank held Cigna as of Q2 2026.
Based on Lipe & Dalton's 13F filing for Q2 2026, filed 14 Jul 2026.